Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5374401 | 0.98 | CA2 (0.42) | CA2CA1CA9TLR8SMN1; SMN2 | |
| SCHEMBL3939833 | 0.94 | CA2 (0.42) | CA2CA1CA9TLR8SMN1; SMN2 | |
| SCHEMBL3937543 | 0.86 | CA2 (0.38) | CA2CA1CA9SMN1; SMN2HTT | |
| SCHEMBL9750154 | 0.81 | ALOX5 (0.47) | CA2HTTMEN1KMT2AMAPT | |
| SCHEMBL5373002 | 0.81 | CA2 (0.47) | CA2CA1CA9TLR8SMN1; SMN2 | |
| SCHEMBL3937091 | 0.80 | POLB (0.52) | CA2CA1CA9SMN1; SMN2HTT | |
| SCHEMBL5380917 | 0.80 | CA2 (0.46) | CA2CA1CA9TLR8SMN1; SMN2 | |
| SCHEMBL11801651 | 0.79 | CA2 (0.42) | CA2CA1CA9TLR8SMN1; SMN2 | |
| SCHEMBL11801662 | 0.79 | GABRP (0.39) | CA2CA1CA9TLR8SMN1; SMN2 | |
| SCHEMBL174991 | 0.78 | TLR8 (0.43) | TLR8GPR84HTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100475912-C | Halogen-free resin composition | CHANG CHUN PLASTICS CO LTD (CN) | 2009-04-08 | — | — | CN | disclosed |
| CN-1333014-C | Halogen-free resin composition | CHANGCHU ARTIFICIAL RESIN FACT (CN) | 2007-08-22 | — | — | CN | disclosed |
| US-7202359-B2 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2007-04-10 | — | — | US | disclosed |
| US-7084194-B2 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2006-08-01 | — | — | US | disclosed |
| US-6900269-B2 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-05-31 | — | — | US | disclosed |
| US-20050085634-A1 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-04-21 | — | — | US | disclosed |
| CN-1580127-A | Halogen-free resin composition | CHANGCHU ARTIFICIAL RESIN FACT (CN) | 2005-02-16 | — | — | CN | disclosed |
| CN-1580128-A | Halogen-free resin composition | CHANGCHUN ARTIFICIAL RESIN FAC (CN) | 2005-02-16 | — | — | CN | disclosed |
| US-20040158023-A1 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-08-12 | — | — | US | disclosed |
| US-20040147640-A1 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-07-29 | — | — | US | disclosed |
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | AOX1, KDM1A, BMI1 | CA2 4496/4885CA1 2550/4885CA9 3200/4885 |
| US-20050085634-A1 | Azaoxa heterocyclic compound and method of preparing the same | AOX1, KDM1A, BMI1 | CA2 4419/4885CA1 2562/4885CA9 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.